Literature DB >> 25609910

The use of endoillumination probe-assisted Descemet membrane endothelial keratoplasty for bullous keratopathy secondary to argon laser iridotomy.

Akira Kobayashi1, Hideaki Yokogawa1, Natsuko Yamazaki1, Toshinori Masaki1, Kazuhisa Sugiyama1.   

Abstract

PURPOSE: To report the first case of Descemet membrane endothelial keratoplasty (DMEK) for bullous keratopathy (BK) secondary to argon laser iridotomy (ALI). PATIENT: A 71-year-old woman presented with decreased visual acuity in her right eye due to BK secondary to ALI that was performed 10 years prior.
RESULTS: Phacosurgery was performed first, followed by successful DMEK 4 months later. A DMEK shooter was used for donor insertion, which allowed for a stable anterior chamber during donor insertion, even when the anterior chamber was quite shallow. Also, removal of edematous epithelial cells and endoillumination probe-assisted DMEK was quite useful to visualize DMEK graft on the background of the dark brown iris seen in Asian eyes. The patient's best corrected visual acuity rapidly increased from 20/200 to 25/20 after 1 month, with complete resolution of corneal edema.
CONCLUSION: We reported the first successful DMEK case for BK secondary to ALI. The use of a DMEK shooter for donor insertion and endoillumination assistance to visualize the DMEK graft was a useful technique for BK secondary to ALI.

Entities:  

Keywords:  DMEK; argon laser iridotomy; bullous keratopathy; endoillumination

Year:  2015        PMID: 25609910      PMCID: PMC4294022          DOI: 10.2147/OPTH.S74981

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

To date, Descemet-stripping automated endothelial keratoplasty (DSAEK) has been the most popularized endothelial keratoplasty technique to treat bullous keratopathy (BK).1,2 We have previously reported for the first time the usefulness of DSAEK for BK secondary to argon laser iridotomy (ALI); these patients usually have small eyes with a shallow anterior chamber, making DSAEK quite challenging.3–6 Recently, to achieve better and more rapid visual acuity when compared to DSAEK, selective transplantation of only donor Descemet membrane (DM) and endothelium was established, and the procedure has been called DM endothelial keratoplasty (DMEK).7–9 Herein, we report the first successful DMEK case for BK secondary to ALI. A surgical technique using endoillumination probe-assisted DMEK was presented.

Patient

This study was approved by the ethics committee of the Kanazawa University Graduate School of Medical Science (Kanazawa, Japan) and followed the tenets of the Declaration of Helsinki. A 71-year-old woman presented with decreased visual acuity (20/200) in her right eye due to BK secondary to ALI that was performed 10 years prior (Figure 1A). The patient had hypertension and rheumatoid arthritis.
Figure 1

Slit-lamp photo before and after DMEK.

Notes: (A) Before surgery, severe bullous keratopathy secondary to argon laser iridotomy was noted in the right eye. (B) One week after DMEK, a crystal clear cornea was observed. The patient’s best corrected visual acuity improved rapidly to 25/20.

Abbreviation: DMEK, Descemet membrane endothelial keratoplasty.

Results

Surgery

The surgery was performed at the Department of Ophthalmology, Kanazawa University Graduate School of Medical Science. The patient read and signed an informed consent form prior to surgery. Cataract surgery (phacoemulsification and intraocular lens implantation) was performed in the 4 months prior to DMEK. Both cataract and DMEK surgery were performed under peribulbar anesthesia. DMEK was performed according to methods previously reported.7,8 In brief, after removal of the edematous host epithelial cells for better visualization of the anterior chamber, the host DM was removed (approximately 9.0 mm in diameter) under viscoelastic materials, which filled the anterior chamber (Figure 2A). An inferior iridectomy at the 6 o’clock position was created using a 25-gauge vitreous cutter. Then, the donor graft was prepared using the submerged cornea with a backgrounds away technique (Figure 2B). The harvested and stained DM roll stained by trypan blue (8.0 mm in diameter) was then inserted into the anterior chamber via a 2.4 mm temporal clear corneal incision using a DMEK shooter (G-38630; GEUDER AG, Heidelberg, Germany) (Figures 2C and D). After securing the wound with a 10-0 nylon suture, the DMEK roll was correctly oriented with the endothelium side facing down. A small air bubble was then injected over the DM graft and used to unfold the DM graft (Figures 2E–G). To obtain further visualization, oblique light via an endoillumination probe held by an assistant surgeon was used (Figures 2E–G). The endoillumination probe was not inserted into the anterior chamber, but attached at the peripheral cornea. This technique improved the contrast between the blue-stained DM roll and the background of the dark brown iris. Finally, the anterior chamber was filled with air to attach the DM graft completely to the posterior stromal surface (Figure 2H). No corneal fenestrations were made to drain the interface fluid. No recipient peripheral stromal scraping was performed to improve donor recipient adhesion. The anterior chamber was left full of air, and the patient was instructed to lie on her back for 2–3 hours.
Figure 2

Surgical technique of endoillumination-assisted DMEK.

Notes: (A) After removal of the host epithelial membrane for better visualization of the anterior chamber, the host DM was removed under viscoelastic materials that filled the anterior chamber. (B) The donor graft was prepared using the submerged cornea with a backgrounds away technique. (C and D) The harvested and stained DM roll stained by trypan blue was then inserted into the anterior chamber using a DMEK shooter. (E–G) The DMEK roll was correctly oriented with the endothelium side facing down. A small air bubble was then used to unfold the DM graft. To obtain further visualization, oblique light via an endoillumination probe held by an assistant surgeon was used. This technique improved the contrast between the blue-stained DM roll and the background of the dark brown iris. (H) Finally, the anterior chamber was filled with air to attach the DM graft completely to the posterior stromal surface.

Abbreviations: DMEK, Descemet membrane endothelial keratoplasty; DM, De scemet membrane.

Clinical outcomes

Intra- and postoperative complications, including graft dislocation, pupillary air block, and rejection, were not noted. The best corrected visual acuity in the patient’s right eye rapidly increased to 25/20 after 1 month, with complete resolution of corneal edema (Figure 1B). Postoperative endothelial cell count after 1 month was 2,212 cells/mm2, a 17.5% reduction when compared with donor counts (2,682 cells/mm2).

Discussion

BKs secondary to ALI are quite common in Japan.3–6 However, patients usually have small eyes with a shallow anterior chamber; this makes endothelial keratoplasty quite challenging.3 In particular, a donor insertion step using a conventional donor taco-folding push-in technique caused severe complications such as iris prolapse, iris bleeding and, in severe cases, vitreous prolapse with serious endothelial cell damage.6 To circumvent these difficulties, we developed the double-glide pull-through technique using a Busin glide together with an intraocular lens sheet glide (also known as Kobayashi’s double-glide technique).6 Herein, we reported the first successful DMEK case for BK secondary to ALI. DMEK for ALI was technically difficult in two ways. First, to insert the DM roll into a shallow anterior chamber using an implantable collamer lens inserter is difficult. Therefore, we found it quite useful to use a DMEK shooter for these eyes, which allowed for a stable anterior chamber during DM roll insertion. In general, the anterior chamber is quite shallow in patients after they have undergone ALI, even when the patient is pseudophakic. Second, the background of a dark brown iris, which is usually seen in Asian eyes, makes the visibility of the blue-stained DMEK donor graft difficult. To circumvent this difficulty, we used oblique light via an endoillumination probe held by an assistant surgeon, which significantly improved the visibility of the DMEK graft in the anterior chamber.

Conclusion

In conclusion, we reported the first successful DMEK case for BK secondary to ALI. The use of the DMEK shooter for donor insertion and endoillumination assistance to visualize the DMEK graft was a useful technique for BK secondary to ALI. Further clinical studies using a large number of cases are required to confirm the usefulness of these techniques.
  9 in total

1.  Posterior lamellar keratoplasty: DLEK to DSEK to DMEK.

Authors:  Gerrit R J Melles
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

2.  National survey on bullous keratopathy in Japan.

Authors:  Jun Shimazaki; Shiro Amano; Toshihiko Uno; Naoyuki Maeda; Norihiko Yokoi
Journal:  Cornea       Date:  2007-04       Impact factor: 2.651

3.  Standardized "no-touch" technique for descemet membrane endothelial keratoplasty.

Authors:  Isabel Dapena; Kyros Moutsouris; Konstantinos Droutsas; Lisanne Ham; Korine van Dijk; Gerrit R J Melles
Journal:  Arch Ophthalmol       Date:  2011-01

4.  Descemet-stripping automated endothelial keratoplasty.

Authors:  Mark S Gorovoy
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

5.  In vivo laser confocal microscopy after Descemet's membrane endothelial keratoplasty.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Natsuko Yamazaki; Toshinori Masaki; Kazuhisa Sugiyama
Journal:  Ophthalmology       Date:  2013-02-04       Impact factor: 12.079

6.  Descemet stripping with automated endothelial keratoplasty for bullous keratopathies secondary to argon laser iridotomy--preliminary results and usefulness of double-glide donor insertion technique.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Kazuhisa Sugiyama
Journal:  Cornea       Date:  2008-09       Impact factor: 2.651

7.  Multicenter study of descemet membrane endothelial keratoplasty: first case series of 18 surgeons.

Authors:  Claire Monnereau; Ruth Quilendrino; Isabel Dapena; Vasilios S Liarakos; Jose F Alfonso; Francisco Arnalich-Montiel; Matthias Böhnke; Nicolas Cesário Pereira; Martin Dirisamer; John Parker; Konstantinos Droutsas; Gerd Geerling; Georg Gerten; Hassan Hashemi; Akira Kobayashi; Miguel Naveiras; Oganes Oganesyan; Emeterio Orduña Domingo; Siegfried Priglinger; Pavel Stodulka; José Torrano Silva; Davide Venzano; Jan Markus Vetter; Evan Yiu; Gerrit R J Melles
Journal:  JAMA Ophthalmol       Date:  2014-10       Impact factor: 7.389

8.  Non-Descemet stripping automated endothelial keratoplasty for endothelial dysfunction secondary to argon laser iridotomy.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Kazuhisa Sugiyama
Journal:  Am J Ophthalmol       Date:  2008-07-09       Impact factor: 5.258

9.  Argon laser iridotomy-induced bullous keratopathy a growing problem in Japan.

Authors:  Leonard P K Ang; Hisayo Higashihara; Chie Sotozono; Vijay A Shanmuganathan; Harminder Dua; Donald T H Tan; Shigeru Kinoshita
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

  9 in total
  11 in total

1.  Endothelial cell loss and graft survival after penetrating keratoplasty for laser iridotomy-induced bullous keratopathy.

Authors:  Naoki Okumura; Ayaka Kusakabe; Noriko Koizumi; Koichi Wakimasu; Kanae Kayukawa; Masami Kondo; Kazuhiko Mori; Chie Sotozono; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2018-05-15       Impact factor: 2.447

2.  Visualization of precut DSAEK and pre-stripped DMEK donor corneas by intraoperative optical coherence tomography using the RESCAN 700.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Natsuko Mori; Kazuhisa Sugiyama
Journal:  BMC Ophthalmol       Date:  2016-08-04       Impact factor: 2.209

3.  Techniques for Learning Descemet Membrane Endothelial Keratoplasty for Eyes of Asian Patients With Shallow Anterior Chamber.

Authors:  Takahiko Hayashi; Itaru Oyakawa; Naoko Kato
Journal:  Cornea       Date:  2017-03       Impact factor: 2.651

4.  Chandelier Illumination for Descemet Membrane Endothelial Keratoplasty.

Authors:  Toshiki Shimizu; Takahiko Hayashi; Kentaro Yuda; Ayako Tsuchiya; Itaru Oyakawa; Nobuhisa Mizuki; Naoko Kato
Journal:  Cornea       Date:  2017-09       Impact factor: 2.651

5.  Descemet membrane endothelial keratoplasty using ophthalmic viscoelastic devices for eyes with laser iridotomy-induced corneal endothelial decompensation: Analysis of 11 eyes.

Authors:  Takahiko Hayashi; Itaru Oyakawa; Akiko Matsuzawa; Kentaro Yuda; Toshiki Shimizu; Ayako Tsuchiya; Nobuhisa Mizuki; Naoko Kato
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  A 10-year review of underlying diseases for endothelial keratoplasty (DSAEK/DMEK) in a tertiary referral hospital in Japan.

Authors:  Tsubasa Nishino; Akira Kobayashi; Hideaki Yokogawa; Natsuko Mori; Toshinori Masaki; Kazuhisa Sugiyama
Journal:  Clin Ophthalmol       Date:  2018-08-06

7.  Case series and techniques of Descemet's Stripping Automated Endothelial Keratoplasty for severe bullous keratopathy after birth injury.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Natsuko Mori; Kazuhisa Sugiyama
Journal:  BMC Ophthalmol       Date:  2015-08-06       Impact factor: 2.209

8.  Endoilluminator-assisted Descemet membrane endothelial keratoplasty and endoilluminator-assisted pre-Descemet endothelial keratoplasty.

Authors:  Soosan Jacob; Amar Agarwal; Dhivya Ashok Kumar
Journal:  Clin Ophthalmol       Date:  2015-11-16

9.  Development of a Donor Tissue Holding Technique for Descemet's Membrane Endothelial Keratoplasty Using a 25-Gauge Graft Manipulator.

Authors:  Akira Kobayashi; Hideaki Yokogawa; Natsuko Mori; Toshinori Masaki; Kazuhisa Sugiyama
Journal:  Case Rep Ophthalmol       Date:  2018-10-11

10.  Microscope Integrated Intraoperative Optical Coherence Tomography-Guided DMEK in Corneas with Poor Visualization.

Authors:  Namrata Sharma; Pranita Sahay; Prafulla K Maharana; Praveen Kumar; Saima Ahsan; Jeewan S Titiyal
Journal:  Clin Ophthalmol       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.